(To see other currencies, click on price)
MORE ABOUT THIS BOOK
Main description:
Progress in basic research has made it necessary to redetermine the possibility of classic endocrine therapy for the treatment of patients with breast cancer. Exemplary, close cooperation between biochemis try and animal and clinical research led to a truly interdisciplinary and international exchange of ideas and experience at a symposium held in autumn 1978 in Heidelberg. We owe our thanks to ICI-Pharma for the kind support of this sym posIUm. The participation of Charles Huggins in the meeting as honorary chairman signified to all participants the meaning of this joint endeavour. It was the same Charles Huggins who through experimental work laid the foundation stone for endocrine ther apy of prostate and breast cancer, and who applied his findings clinically. Thousands of patients owe to him relief from their suffering. He contributed greatly to the attempt to find and stabilize the endocrine therapy for breast cancer, for which we thank him sincerely. We hope that the following contributions will similarly serve the well-being of our patients.
Contents:
I. Improved Biochemical Characterization of Breast Cancer.- 1. Improved Biochemical Characterization of Breast Cancer as a Guide to Hormonal Treatment.- 2. Steroid Receptor Determinations in Mammary Carcinoma in Women.- 3. Steroid Receptor Determination by Means of Agar Gel Electrophoresis.- 4. Estrogen Receptor Determination Predicts Response to Tamoxifen Therapy.- 5. Estrogen Receptor Status and the Disease-Free Interval in Breast Cancer.- 6. Clinical Predictive Criteria for Response to Endocrine Treatment and the Receptor Status.- II. Antiestrogens in Experimental Breast Cancer.- 7. Anti-Oestrogen Action in Experimental Breast Cancer.- 8. Studies on Mechanisms of Estrogen and Antiestrogen Action in Human Breast Cancer.- 9. Human Breast Cancer in Nude Mice: A Model for Testing Endocrine Treatment.- 10. A Hormone-Dependent Human Breast Cancer Cell Line Grown in Defined Medium.- 11. Endocrine and Cytostatic Treatment of Experimental Mammary Cancer.- 12. The Direct Inhibition of Prostaglandin Synthetase of Human Breast Cancer Tumour Tissue by Tamoxifen.- III. Endocrine Treatment of Advanced Breast Cancer.- 13. Endocrine Treatment of Advanced Breast Cancer.- 14. Principles and Indications of Endocrine Treatment of Advanced Breast Cancer.- 15. Ablation of the Hypophysis by Radioactive Gold in Metastatic Mammary Carcinoma.- 16. Anti-Oestrogens: An Alternative to Ablative Endocrine Therapy?.- IV. Anti-Oestrogens in the Treatment of Advanced BreastCancer.- 17. Tamoxifen in Advanced Breast Cancer: Experience of the SAKK (Schweizerische Arbeitsgruppe fur Klinische Krebsforschung - Swiss Cooperative Oncology Group).- 18. Therapeutic Effect of Tamoxifen Related to Estrogen Receptor Level.- 19. Results of Tamoxifen Therapy in Patients with Breast Cancer.- 20. Results with Tamoxifen in Advanced Mammary Carcinoma.- 21. The Significance of Tumour "Stimulation" by Tamoxifen.- V. Combination Therapy of Advanced Breast Cancer.- 22. Simultaneous Hormone- and Chemotherapy, Compared with Hormone Therapy Followed by Chemotherapy in the Treatment of Metastasising Mammary Carcinoma - Preliminary Results of a Current Study.- 23. Lack of Estrogen Receptor Associated with an Increased Response Rate to Cytotoxic Chemotherapy in Metastatic Breast Cancer?.- 24. The Influence of Polychemotherapeutic Regimen on the Female Endocrine Control Mechanisms in Mammary Carcinoma Patients.- 25. Therapeutic Effect of Tamoxifen Alone Versus Tamoxifen in Combination with Gestagen and Oestrogen in Advanced Breast Cancer.- VI. Adjuvant Endocrine Therapy of Breast Cancer.- 26. Is There a Place for Adjuvant Endocrine Therapy of Breast Cancer?.- 27. Adjuvant Endocrine Therapy of Breast Cancer - A Controlled Clinical Trial of Oestrogen and Anti-Oestrogen: Preliminary Results of the Copenhagen Breast Cancer Trials.- VII. Principles of Clinical Trials.- 28. Principles of Clinical Trials.- 29. Establishment of Uniformity in Steroid Receptor Analyses Used in Cooperative Clinical Trials of Breast Cancer Treatment.- VIII. Anti-Oestrogen Treatment in Breast Cancer - A Comprehensive Review.- 30. Clinical Experience with Tamoxifen in Advanced Breast Cancer.- 31. The Place of Tamoxifen in the Treatment of Breast Cancer.- Final Remarks.
PRODUCT DETAILS
Publisher: Springer (Springer-Verlag Berlin and Heidelberg GmbH & Co. K)
Publication date: December, 2011
Pages: 252
Weight: 442g
Availability: Not available (reason unspecified)
Subcategories: Endocrinology, Obstetrics and Gynaecology, Oncology
From the same series
Friedhelm Raue
Thomas Ried
Christian Wittekind
Florian Otto
Markus W. Buchler
C. Stroszczynski
Manfred Dietel
H.-J. Senn
Otmar Schober
Jean-Nicolas Vauthey
Elmar Detering
Richard P. Baum
G. Mathe
R. Gross
Florian Otto
Uwe M. Martens
Michail Ignatiadis
Georges Mathe
M. S. Griem
Jack Cuzick
Michael Gnant
Ute Goerling
Hans-Jorg Senn
Werner H. Kirsten
F.A. Langley
Kuan-Teh Jeang
Janusz Jankowski
J. Bernard
Thomas Moehler
Andrea Tannapfel
S.K. Carter
R. S. Nelson
Kerry S. Courneya
Rolf D. Issels
Hans-Jorg Senn
Florian Otto
W. Fischbach
Umberto Veronesi
Otmar Schober
Paul M. Schneider
Hans-Jorg Senn
Wolfgang Tilgen
Jean-Nicolas Vauthey
Richard P. Baum
J. L. Hayward
W. H. Kirsten
Henry T. Lynch
Georges Mathe
G. T. Pack
Leon Goldman
Charles G. Moertel
R.G. Freeman
L. Manuila
Agnes Glaus
Rudiger Liersch
Richard Schindler
Uwe M. Martens
W.A. Fuchs
Michail Ignatiadis
Edward S. Meek
P. Roy-Burman
Merle Mizell
Jean Lindenmann
Pavel Koldovsky
Enrico Anglesio
Georges Mathe
Hans-Jorg Senn
James H. Goldie
Donald Metcalf
Siegfried Seeber
Israel Penn
B. Sokoloff
Manfred Schwab
E. Grundmann
H.-D. Pape
Robert S. Nelson
G. Mathe
J. Lange
G. Bonadonna
J. Szymendera
H. B. Marsden
K. E. Stanley
E. Grundmann
C. Bohuon
Pierre Denoix
A. C. Templeton
Ekkehard Grundmann
Michael Wannenmacher
Ivan Damjanov
Wolf-Dieter Ludwig
Friedhelm Raue
M. L. Jacobs
H.K. Muller-Hermelink
Rita Engenhart-Cabillic
E. Grundmann
Peter M Schlag
E. Grundmann
Ekkehard Grundmann
G. Mathe
Donald Metcalf
S. Brunner
F. F. Holmes
G. Mathe
G. Mathe
Pierre Band
Stephen C. Schimpff
K. Schwemmle
Michael Gnant
K. Hoffken
Friedhelm Raue
H. R. Scheurlen
Aron Goldhirsch
H. Acker
Hans-Jorg Senn
F. G. J. Hayhoe
William Duncan
E. Thiel
Hans-Jorg Senn
K. Musshoff
Hans-Jorg Senn
A. Rossi-Fanelli
Peo C. Koller
Volker Diehl
K. Hoffken
H.-J. Senn
Bruce S. Schoenberg
G. St. Arneault
S.K. Carter
J. Hekmatpanah
G. Mathe
E. Grundmann
Hans-Jorg Senn
G. Mathe
Sam Brunner
Hans-Jorg Senn
V. Hofmann
Michael Wannenmacher
G. Wagner
Hans-Jorg Senn
Rudolf Pichlmayr
Frank M. Torti
Michael Wannenmacher
William Duncan
G. Mathe
M. Bamberg
H.-P. Lohrmann
E. Grundmann
Niels Neymark
Peter M Schlag
P. Koldovsky
G. Nass
W. Duncan
Ekkehard Grundmann
Richard P. Gallagher
Hans-Jorg Senn
W. Duncan
W. Duncan
S.K. Carter
Michael Molls
Sam Brunner
Peter Boyle
Maurizio Ponz de Leon
U. Reinhold
Gunter Burg
K. Hoffken
H.-J. Senn
F.W. Schildberg
Beat Thurlimann
Janusz Jankowski
Thomas Moehler
Andrea Tannapfel
Kerry S. Courneya
H.-J. Senn
Per-Ulf Tunn
Andreas von Deimling
Antonella Surbone
Ursula Kapp
Hans-Jorg Senn
Santiago Gonzalez-Moreno
Hanno Riess
Paul M. Schneider
Uwe M. Martens
Rudiger Liersch
Renzo Brun del Re
Andreas von Deimling
Ursula Kapp
Per-Ulf Tunn
Hanno Riess
Antonella Surbone
Manfred Dietel
Santiago Gonzalez-Moreno
Louis Denis
H.-J. Senn
C. Stroszczynski